Jilin Province Huinan Changlong Bio-pharmacy Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
For the nine months, sales was CNY 592.84 million compared to CNY 593.42 million a year ago. Net income was CNY 133.3 million compared to CNY 104.66 million a year ago. Basic earnings per share from continuing operations was CNY 0.2379 compared to CNY 0.1868 a year ago.